全球医师配药药妆市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

全球医师配药药妆市场的需求预计将从 2023 年的 113.3 亿美元达到 2032 年近 233.3 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 8.35%。

医生配药药妆品是指医生推荐的各种化妆品，这些产品经过特殊配製，可以在有或没有其他治疗（例如手术或肉毒桿菌）的情况下提供更好的效果。这些产品与非处方药产品的不同之处在于其配方、品质和强度。医生级药妆品含有更高浓度的胜肽和维生素 C。在有执照的皮肤护理专业人士的知识丰富的指导下，它们提供更多的多功能性来匹配患者的皮肤、状况和生活方式。它们具有不同的强度、配方和浓度，可满足所有不同的皮肤类型和要求。

市场动态

护肤品需求的显着增长以及患者开始依赖皮肤科医生和美容医生推荐适合其皮肤、头髮和指甲的产品将成为医生配药药妆品的主要趋势因素。压力和污染水平的上升导致城市人口皮肤、头髮和眼睛的伤害增加，这将有利于市场的成长。针对多种医疗状况的新型、先进药妆品的研发将进一步推动市场成长。根据皮肤科医师的建议，各种专门从事药妆品製造和行销的化妆品新创公司将对市场产生积极影响。草药新概念的出现将增加对有机医师配製药妆品的需求。市场领导者制定的高品质标准和严格的政府法规几乎不会成为市场的障碍。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球医师配製药妆市场的各个细分市场进行了包容性评估。医师配药药妆产业的成长和趋势为本研究提供了整体方法。

市场区隔

医师配药药妆市场报告的这一部分提供了有关国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

依产品类型

• 脸部护理
• 保养品

按指示

• 皮肤美白或脱色
• 减少皮纹
• 抗皱/抗衰老
• 减少疤痕
• 其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲的医师配药药妆市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。医师配药药妆市场的主要参与者包括艾伯维公司（艾尔建）、欧莱雅公司、Jan Marini Skin Research Inc.、Athena Cosmetics Inc.、ZO Skin Health Inc.、Galderma Laboratories, LP、宝洁公司。 The EsteE Lauder Companies Inc.、Merz Pharma、Obagi Cosmeceuticals LLC、IS CLINICAL、Neutrogena、Velius LLC、Sonoma Pharmaceuticals Inc.、Sientra Inc.、Dynamic Techno Medicals、Implantech Associates Inc. 本部分包含竞争产品的整体视图包括各种策略发展，如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：医师配药化妆品 - 产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业动态
• 波特五力分析
• 市场吸引力分析
  • 市场吸引力分析：按产品类型
  • 按指标进行的市场吸引力分析
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料厂商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第 5 章：全球医师配製药妆品市场分析：依产品类型

• 概述：按产品类型
• 历史与预测资料分析：按产品类型
• 脸部护理
• 保养品

第 6 章：全球医师配药妆品市场分析：依适应症分类

• 按指示概述
• 按指示进行历史和预测资料分析
• 皮肤美白或脱色
• 减少皮纹
• 抗皱/抗衰老
• 减少疤痕
• 其他的

第 7 章：全球医师配製药妆品市场分析：依地理位置

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史与预测资料销售分析
  • 北美按细分市场销售分析
  • 北美按国家销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史与预测资料销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史与预测资料销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区按国家销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史与预测资料销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史与预测资料销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲按国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 8 章：医师配製药妆公司的竞争格局

• 医师配药药妆市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 9 章：公司简介

• 顶级公司市占率分析
• 市场集中度
• AbbVie Inc. (Allergan)
• 公司概况
• 公司收入
• 产品
• 最新动态
• L'Oreal SA
• 公司概况
• 公司收入
• 产品
• 最新动态
• Jan Marini Skin Research Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Athena Cosmetics Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• ZO Skin Health Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Galderma Laboratories
• 公司概况
• 公司收入
• 产品
• 最新动态
• LP
• 公司概况
• 公司收入
• 产品
• 最新动态
• Procter & Gamble Co.
• 公司概况
• 公司收入
• 产品
• 最新动态
• The EsteE Lauder Companies Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Merz Pharma
• 公司概况
• 公司收入
• 产品
• 最新动态
• Obagi Cosmeceuticals LLC
• 公司概况
• 公司收入
• 产品
• 最新动态
• IS CLINICAL
• 公司概况
• 公司收入
• 产品
• 最新动态
• Neutrogena
• 公司概况
• 公司收入
• 产品
• 最新动态
• Velius LLC
• 公司概况
• 公司收入
• 产品
• 最新动态
• Sonoma Pharmaceuticals Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Sientra Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Dynamic Techno Medicals
• 公司概况
• 公司收入
• 产品
• 最新动态
• Implantech Associates Inc
• 公司概况
• 公司收入
• 产品
• 最新动态

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

The global demand for Physician Dispensed Cosmeceuticals Market is presumed to reach the market size of nearly USD 23.33 Billion by 2032 from USD 11.33 Billion in 2023 with a CAGR of 8.35% under the study period 2024-2032.

Physician dispensed cosmeceuticals refer to the various cosmetic products recommended by physicals that are specially compounded to offer heightened results with or without other treatments, such as surgery or Botox. These products differ from the OTC counterparts in the way they are formulated and their quality and strength. Physician-grade cosmeceuticals contain more substantial concentrations of peptides and Vitamin C. The concentration and delivery of peptides have a more significant impact on the appearance of the skin by encouraging better fibroblast activity or collagen synthesis. With the knowledgeable guidance of a licensed skincare professional, they offer far more versatility to match a patient's skin, condition, and lifestyle. They come in various strengths, formulations, and concentrations to fit all different skin types and requirements.

MARKET DYNAMICS

The significant growth in the demand for skincare and patients beginning to rely on dermatologists and cosmetic physicians to recommend suitable products for their skin, hair, and nails will be the main trending factors for physician-dispensed cosmeceuticals. The rising levels of stress and pollution causing increased damage to the skin, hair, and eyes among the urban population will benefit market growth. Research and development of newer and advanced cosmeceuticals to target several medical conditions will further propel market growth. Various cosmetic startups specializing in the manufacture and marketing of cosmeceuticals, as advised by dermatologists, will positively impact the market. The emergence of the novel concept of herbal medicine will boost the demand for organic physician dispensed cosmeceuticals. High-quality standards set by market leaders and stringent government regulations are few hindrances to the market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Physician Dispensed Cosmeceuticals. The growth and trends of Physician Dispensed Cosmeceuticals industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Physician Dispensed Cosmeceuticals market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

• Face-care
• Skincare

By Indication

• Skin Lightening or De-pigmenting
• Rhytide Reduction
• Anti-Wrinkle/Aging
• Scar-reducing
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Physician Dispensed Cosmeceuticals market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Physician Dispensed Cosmeceuticals market include AbbVie Inc. (Allergan), L'Oreal S.A., Jan Marini Skin Research Inc., Athena Cosmetics Inc., ZO Skin Health Inc., Galderma Laboratories, L.P., Procter & Gamble Co., The EsteE Lauder Companies Inc., Merz Pharma, Obagi Cosmeceuticals LLC, IS CLINICAL, Neutrogena, Velius LLC, Sonoma Pharmaceuticals Inc., Sientra Inc., Dynamic Techno Medicals, Implantech Associates Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. PHYSICIAN DISPENSED COSMECEUTICALS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product Type
  • 3.7.2 Market Attractiveness Analysis By Indication
  • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL PHYSICIAN DISPENSED COSMECEUTICALS MARKET ANALYSIS BY PRODUCT TYPE

• 5.1. Overview By Product Type
• 5.2. Historical and Forecast Data Analysis By Product Type
• 5.3. Face-care Historic and Forecast Sales By Regions
• 5.4. Skincare Historic and Forecast Sales By Regions

6. GLOBAL PHYSICIAN DISPENSED COSMECEUTICALS MARKET ANALYSIS BY INDICATION

• 6.1. Overview By Indication
• 6.2. Historical and Forecast Data Analysis By Indication
• 6.3. Skin Lightening or De-pigmenting Historic and Forecast Sales By Regions
• 6.4. Rhytide Reduction Historic and Forecast Sales By Regions
• 6.5. Anti-Wrinkle/Aging Historic and Forecast Sales By Regions
• 6.6. Scar-reducing Historic and Forecast Sales By Regions
• 6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL PHYSICIAN DISPENSED COSMECEUTICALS MARKET ANALYSIS BY GEOGRAPHY

• 7.1. Regional Outlook
• 7.2. Introduction
• 7.3. North America Sales Analysis
  • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.3.2 North America By Segment Sales Analysis
  • 7.3.3 North America By Country Sales Analysis
  • 7.3.4 United States Sales Analysis
  • 7.3.5 Canada Sales Analysis
  • 7.3.6 Mexico Sales Analysis
• 7.4. Europe Sales Analysis
  • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.4.2 Europe By Segment Sales Analysis
  • 7.4.3 Europe By Country Sales Analysis
  • 7.4.4 United Kingdom Sales Analysis
  • 7.4.5 France Sales Analysis
  • 7.4.6 Germany Sales Analysis
  • 7.4.7 Italy Sales Analysis
  • 7.4.8 Russia Sales Analysis
  • 7.4.9 Rest Of Europe Sales Analysis
• 7.5. Asia Pacific Sales Analysis
  • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.5.2 Asia Pacific By Segment Sales Analysis
  • 7.5.3 Asia Pacific By Country Sales Analysis
  • 7.5.4 China Sales Analysis
  • 7.5.5 India Sales Analysis
  • 7.5.6 Japan Sales Analysis
  • 7.5.7 South Korea Sales Analysis
  • 7.5.8 Australia Sales Analysis
  • 7.5.9 South East Asia Sales Analysis
  • 7.5.10 Rest Of Asia Pacific Sales Analysis
• 7.6. Latin America Sales Analysis
  • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.6.2 Latin America By Segment Sales Analysis
  • 7.6.3 Latin America By Country Sales Analysis
  • 7.6.4 Brazil Sales Analysis
  • 7.6.5 Argentina Sales Analysis
  • 7.6.6 Peru Sales Analysis
  • 7.6.7 Chile Sales Analysis
  • 7.6.8 Rest of Latin America Sales Analysis
• 7.7. Middle East & Africa Sales Analysis
  • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.7.2 Middle East & Africa By Segment Sales Analysis
  • 7.7.3 Middle East & Africa By Country Sales Analysis
  • 7.7.4 Saudi Arabia Sales Analysis
  • 7.7.5 UAE Sales Analysis
  • 7.7.6 Israel Sales Analysis
  • 7.7.7 South Africa Sales Analysis
  • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE PHYSICIAN DISPENSED COSMECEUTICALS COMPANIES

• 8.1. Physician Dispensed Cosmeceuticals Market Competition
• 8.2. Partnership/Collaboration/Agreement
• 8.3. Merger And Acquisitions
• 8.4. New Product Launch
• 8.5. Other Developments

9. COMPANY PROFILES OF PHYSICIAN DISPENSED COSMECEUTICALS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Market Concentration Rate
• 9.3. AbbVie Inc. (Allergan)
  • 9.3.1 Company Overview
  • 9.3.2 Company Revenue
  • 9.3.3 Products
  • 9.3.4 Recent Developments
• 9.4. L'Oreal S.A.
  • 9.4.1 Company Overview
  • 9.4.2 Company Revenue
  • 9.4.3 Products
  • 9.4.4 Recent Developments
• 9.5. Jan Marini Skin Research Inc.
  • 9.5.1 Company Overview
  • 9.5.2 Company Revenue
  • 9.5.3 Products
  • 9.5.4 Recent Developments
• 9.6. Athena Cosmetics Inc.
  • 9.6.1 Company Overview
  • 9.6.2 Company Revenue
  • 9.6.3 Products
  • 9.6.4 Recent Developments
• 9.7. ZO Skin Health Inc.
  • 9.7.1 Company Overview
  • 9.7.2 Company Revenue
  • 9.7.3 Products
  • 9.7.4 Recent Developments
• 9.8. Galderma Laboratories
  • 9.8.1 Company Overview
  • 9.8.2 Company Revenue
  • 9.8.3 Products
  • 9.8.4 Recent Developments
• 9.9. L.P.
  • 9.9.1 Company Overview
  • 9.9.2 Company Revenue
  • 9.9.3 Products
  • 9.9.4 Recent Developments
• 9.10. Procter & Gamble Co.
  • 9.10.1 Company Overview
  • 9.10.2 Company Revenue
  • 9.10.3 Products
  • 9.10.4 Recent Developments
• 9.11. The EsteE Lauder Companies Inc.
  • 9.11.1 Company Overview
  • 9.11.2 Company Revenue
  • 9.11.3 Products
  • 9.11.4 Recent Developments
• 9.12. Merz Pharma
  • 9.12.1 Company Overview
  • 9.12.2 Company Revenue
  • 9.12.3 Products
  • 9.12.4 Recent Developments
• 9.13. Obagi Cosmeceuticals LLC
  • 9.13.1 Company Overview
  • 9.13.2 Company Revenue
  • 9.13.3 Products
  • 9.13.4 Recent Developments
• 9.14. IS CLINICAL
  • 9.14.1 Company Overview
  • 9.14.2 Company Revenue
  • 9.14.3 Products
  • 9.14.4 Recent Developments
• 9.15. Neutrogena
  • 9.15.1 Company Overview
  • 9.15.2 Company Revenue
  • 9.15.3 Products
  • 9.15.4 Recent Developments
• 9.16. Velius LLC
  • 9.16.1 Company Overview
  • 9.16.2 Company Revenue
  • 9.16.3 Products
  • 9.16.4 Recent Developments
• 9.17. Sonoma Pharmaceuticals Inc.
  • 9.17.1 Company Overview
  • 9.17.2 Company Revenue
  • 9.17.3 Products
  • 9.17.4 Recent Developments
• 9.18. Sientra Inc.
  • 9.18.1 Company Overview
  • 9.18.2 Company Revenue
  • 9.18.3 Products
  • 9.18.4 Recent Developments
• 9.19. Dynamic Techno Medicals
  • 9.19.1 Company Overview
  • 9.19.2 Company Revenue
  • 9.19.3 Products
  • 9.19.4 Recent Developments
• 9.20. Implantech Associates Inc
  • 9.20.1 Company Overview
  • 9.20.2 Company Revenue
  • 9.20.3 Products
  • 9.20.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Product Type (USD MN)
• Face-care Market Sales By Geography (USD MN)
• Skincare Market Sales By Geography (USD MN)
• Analysis By Indication (USD MN)
• Skin Lightening or De-pigmenting Market Sales By Geography (USD MN)
• Rhytide Reduction Market Sales By Geography (USD MN)
• Anti-Wrinkle/Aging Market Sales By Geography (USD MN)
• Scar-reducing Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global Physician Dispensed Cosmeceuticals Market Sales By Geography (USD MN)
• North America Market Analysis (USD MN)
• United States Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate By Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Physician Dispensed Cosmeceuticals Report
• Market Research Process
• Market Research Methodology
• Global Physician Dispensed Cosmeceuticals Market Size, By Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Product Type
• Market Attractiveness Analysis By Indication
• Market Attractiveness Analysis By Region
• Value Chain Analysis
• Global Market Analysis By Product Type (USD MN)
• Face-care Market Sales By Geography (USD MN)
• Skincare Market Sales By Geography (USD MN)
• Global Market Analysis By Indication (USD MN)
• Skin Lightening or De-pigmenting Market Sales By Geography (USD MN)
• Rhytide Reduction Market Sales By Geography (USD MN)
• Anti-Wrinkle/Aging Market Sales By Geography (USD MN)
• Scar-reducing Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.